Verition Fund Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,417
| Closed | -$746K | – | 2870 |
|
|
2025
Q1 | $746K | Sell |
18,417
-15,018
| -45% | -$608K | ﹤0.01% | 1775 |
|
|
2024
Q4 | $930K | Buy |
+33,435
| New | +$930K | ﹤0.01% | 1572 |
|
|
2024
Q3 | – | Sell |
-9,256
| Closed | -$217K | – | 2448 |
|
|
2024
Q2 | $217K | Buy |
+9,256
| New | +$217K | ﹤0.01% | 1904 |
|
|
2023
Q2 | – | Sell |
-5,360
| Closed | -$205K | – | 1895 |
|
|
2023
Q1 | $205K | Buy |
+5,360
| New | +$205K | ﹤0.01% | 1592 |
|